This page shows the result of browsing biomarker from different fieldss.For more information see HELP page.
The total number entries retrieved from this search are 378Biomarker ID | Biomarker | Biomolecule | Subject | Regulation | Biomarker's type | Experiment | Level of significance | Source | PMID |
---|---|---|---|---|---|---|---|---|---|
2548 | PCNA | Protein | Human | Upregulated in HCC than non-HCC (avg ratio HCC to non-tumor 9.1 +/- 5.4) | Diagnostic | HCC v/s non-tumor | p < 0.05 | Tissue | 15759316 |
2549 | Stathmin 1 | Protein | Human | Upregulated in HCC than non-HCC (avg ratio HCC to non-tumor 11.1 +/- 15.7) | Diagnostic | HCC v/s non-tumor | p < 0.05 | Tissue | 15759316 |
2550 | FGG | Protein | Human | Upregulated in well-differentiated HCC (with 2 fold change) | Diagnostic | HCC v/s non-tumor | p < 0.05 | Tissue | 15852300 |
2551 | Isocitrate dehydrogenase [NADP] (cytoplasmic), Fumarate hydratase (mitochondrial), Enoyl-CoA hydratase (mitochondrial), Betaine-homocysteine S-methyltransferase, Serotransferrin precursor | Protein | Human | Downregulated in well-differentiated HCC (with 2 fold change) | Diagnostic | HCC v/s non-tumor | p < 0.05 | Tissue | 15852300 |
2552 | Aldo-keto reductase family 1 member B10, Alpha-1-antitrypsin precursor | Protein | Human | Upregulated in poorly-differentiated HCC (with 2 fold change) | Diagnostic | HCC v/s non-tumor | p < 0.05 | Tissue | 15852300 |
2553 | Keratin type I cytoskeletal 10, Catalase, Aldehyde dehydrogenase (mitochondrial), GlutathioneS-transferase A1, Antioxidant protein 2, Isocitrate dehydrogenase [NADP] (cytoplasmic), Formiminotransferase-cyclodeaminase, Carbonic anhydrase I, Fructose bisphosphate aldolase B, Arginase 1, Fructose-1, 6- | Protein | Human | Downregulated in poorly-differentiated HCC (with 2 fold change) | Diagnostic | HCC v/s non-tumor | p < 0.05 | Tissue | 15852300 |
2554 | sterol-C5-desaturase, Peroxisomal phytanoyl-CoA alpha-hydroxylase, Homo sapiens clone 23915, Osteopontin 5/6 0, Full-length cDNA clone ZD66D02, Senescence-associated epithelial membrane protein(SEMP1), Human DNA topoisomerase II (top2) mRNA, Homo sapiens lysosomal membrane glycoprotein-2 (LAMP2), Hu | RNAs | Human | Upregulated in HCC than non-tumor | Diagnostic | Tumor v/s normal | NA | Tissue | 12136251 |
2555 | KIAA0959 protein, thymosin beta 4 Y isoform(TB4Y)mRNA, Pig7 (PIG7) mRNA, Fas binding protein (hDaxx), putative lung tumor suppressor(DAL1) mRNA complete cds, novel chemokine family member with altered, mRNA for Src-like adapter protein, OSF-1, Hu lambda-17 lambda-like protein (IGLL2), helix-loop-hel | RNAs | Human | Downregulated in HCC than non-tumor | Diagnostic | Tumor v/s normal | NA | Tissue | 12136251 |
2561 | HSP70 | Protein | Human | Upregulated in early HCC components | Diagnostic and prognostic | nodule-in-nodule-type HCCs and corresponding noncancerous liver tissues | p< .001 | Tissue | 12500205 |
2562 | galectin-3,serine/threonine kinase, translation factor eIF- 4A, -4B, -3, fibroblast growth factor receptor, and ri- bosomal protein L35A | RNAs | Human | Upregulated in HCC | Diagnostic | HCC v/s non-tumor | Tissue | 12521301 | |
2563 | Nip3, decorin, and the insulin-like growth factor binding protein-3 | RNAs | Human | Downregulated in HCC | Diagnostic | HCC v/s non-tumor | Tissue | 12521301 | |
2564 | EFNA1 | Protein and RNAs | Human | Upregulated in HCC | Diagnostic and Prognostic | HCC v/s non-tumor/normal; associated with the poor survival of patients | p< 0.001 | Tissue and Seum | 19642143 |
2565 | EphA2 | Protein and RNAs | Human | Downregulated in HCC | Diagnostic and Prognostic | HCC v/s non-tumor/normal; associated with the poor survival of patients | p < 0.05 | Tissue and Seum | 19642143 |
2566 | Matrixmetalloproteinase14 or MMP14, MT-MMP1,osteonectin/SPARC | RNAs | Human | Upregulated in all three tested HCC samples. | Diagnostic | HCC v/s non-tumor | p < 0.05 | Tissue | 11813304 |
2567 | Cu/Zn-SOD | RNAs | Human | Downregulated in all three tested HCC samples. | Diagnostic | HCC v/s non-tumor | p < 0.07 | Tissue | 11813304 |
2569 | H19 and IGF2 | RNAs | Human | Upregulated in B-type HCC | Diagnostic | HBV-HCC vs HCV -HCC; associated with the progression of HCC | p < 0.05 | Tissue | 12124323 |
2570 | MAP2K4, MAP2K5, SF1, SIAHBP1, and MYOG | RNAs | Human | Upregulated in B-type HCC | Diagnostic | HBV-HCC vs HCV -HCC; associated with the progression of HCC | P< 0.05 | Tissue | 12124323 |
2571 | MMP9 and VEGF | RNAs | Human | Upregulated in B-type HCC | Diagnostic | HBV-HCC vs HCV -HCC; associated with the progression of HCC | P< 0.05 | Tissue | 12124323 |
2572 | MT1E, MT1H, ADH1B, ADH4, CYP2A7, andCYPIIE | RNAs | Human | Upregulated in C-type HCC | Diagnostic | HBV-HCC vs HCV -HCC; associated with the progression of HCC | P< 0.05 | Tissue | 12124323 |
2573 | BMP4, FLNB, GNG11, GFR, and PTPRK | RNAs | Human | Upregulated in HBV-HCCs from patients with LC | Diagnostic | HBV-HCCs patients with LC (liver cirrhosis) vs without LC (liver cirrhosis) | P< 0.05 | Tissue | 12771952 |
2574 | NFIB,GFI1,TAF1,ONECUT1,BTF,andTRIM32 | RNAs | Human | Upregulated in HBV-HCCs from patients with LC | Diagnostic | HBV-HCCs patients with LC (liver cirrhosis) vs without LC (liver cirrhosis) | P< 0.05 | Tissue | 12771952 |
2575 | APOC1, APOC2, andAPOC3 | RNAs | Human | Upregulated in HBV-HCCs from patients with LC | Diagnostic | HBV-HCCs patients with LC (liver cirrhosis) vs without LC (liver cirrhosis) | P< 0.05 | Tissue | 12771952 |
2576 | IGF2 | RNAs | Human | Upregulated in HBV-HCCs from patients with LC | Diagnostic | HBV-HCCs patients with LC (liver cirrhosis) vs without LC (liver cirrhosis) | P< 0.05 | Tissue | 12771952 |
2577 | PHB | RNAs | Human | Downregulated in HBV-HCCs from patients with LC | Diagnostic | HBV-HCCs patients with LC (liver cirrhosis) vs without LC (liver cirrhosis) | P< 0.05 | Tissue | 12771952 |
2578 | IGFBP3 | RNAs | Human | Downregulated in HBV-HCCs from patients with LC | Diagnostic | HBV-HCCs patients with LC (liver cirrhosis) vs without LC (liver cirrhosis) | P< 0.05 | Tissue | 12771952 |
2579 | HSPA1B | RNAs | Human | Downregulated in HBV-HCCs from patients with LC than HBV-HCCs without LC | Diagnostic | HBV-HCCs patients with LC (liver cirrhosis) vs without LC (liver cirrhosis) | P< 0.05 | Tissue | 12771952 |
2588 | NM23-H2,MCM7, PARP1, YWHAH, HSPB1, MSH2 | RNAs | Human | Upregulated in tumor | Diagnostic | HCC v/s non-tumor | P<0.001 | Tissue | 16703398 |
2589 | MT1A, MT3 | RNAs | Human | downregulated in tumor | Diagnostic | HCC v/s non-tumor | P<0.001 | Tissue | 16703398 |